Transaktionen anzeigen
Gesundheitswesen | TMT

ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners

Netherlands-based ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning software to improve early detection of breast cancer, has raised US$28 million (€24 million) in a Series C funding round led by New York-based global venture capital and private equity firm Insight Partners to further develop its technology and accelerate commercial growth of the company’s Transpara AI breast care software.

Founded in 2014 by Professor Nico Karssemeijer and Professor Sir Michael Brady and based in Nijmegen, the Netherlands, ScreenPoint Medical develops and markets innovative machine learning solutions to improve breast cancer screening and diagnosis. With its market-leading AI solution Transpara, ScreenPoint Medical supports radiologists in evaluating mammograms to detect breast cancer and allows them to improve the quality and efficiency of breast cancer screening. Transpara is currently used in over 200 clinics in 25 countries worldwide.

Insight Partners is a US-based venture capital and private equity firm with more than US$30 billion in capital commitments. With its experience and track record of investing in high-growth technology and software companies that drive transformative change in their industries, Insight Partners is ideally situated to support ScreenPoint Medical with its endeavors. Alongside Insight Partners, University Radiology Group, one of the largest providers of sub-specialty radiology and teleradiology services in the United States, participated in the investment round. Existing investors, including ScreenPoint Medical’s founders Siemens Healthineers and Oost NL, will continue to support the company in its further growth and development.

Oaklins’ team in the Netherlands acted as the exclusive advisor to the shareholders and management of ScreenPoint Medical.

About ScreenPoint

ScreenPoint was founded in 2014 as a spin-off from Radboud University Medical Center in Nijmegen, the Netherlands, to develop and bring to market innovative machine learning solutions to improve breast cancer screening and diagnosis. With an exceptional team of specialists in machine learning, image analysis and breast imaging, ScreenPoint developed the market-leading AI solution Transpara for reading mammograms and breast tomosynthesis.

About Insight Partners

Insight Partners is a leading global venture capital and private equity firm investing in high-growth technology and software ScaleUp companies that are driving transformative change in their industries. Founded in 1995, Insight Partners has invested in more than 400 companies worldwide and has raised through a series of funds more than US$30 billion in capital commitments. Insight's mission is to find, fund and work successfully with visionary executives, providing them with practical, hands-on software expertise to foster long-term success. Across its people and its portfolio, Insight encourages a culture around a belief that ScaleUp companies and growth create opportunity for all.

DIENSTLEISTUNG
Beschaffung von Kapital
PARTEIEN
«We are delighted to welcome Insight Partners as a new shareholder of ScreenPoint Medical. Their broad experience and network within the medical technology sector will enable us to further develop and commercialize our AI solution. The support and guidance of the Oaklins team, together with their experience in the medical imaging space, has proven extremely valuable throughout this process.»

Nico Karssemeijer

Founder and CEO

Sprechen Sie mit dem Deal Team

 Robert  Boersma

Robert Boersma

Partner
Amsterdam, Niederlande
Oaklins Netherlands
 Martijn  de Win

Martijn de Win

Associate Director
Amsterdam, Niederlande
Oaklins Netherlands
 Robbert  Bon

Robbert Bon

Associate
Amsterdam, Niederlande
Oaklins Netherlands

Transaktionen

SulAmérica and Rede D’Or São Luiz have announced a combination
Finanzdienstleistungen | Gesundheitswesen

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Mehr erfahren
Optano, a leading provider of AI-powered operations solutions, acquired by A.T. Kearney
TMT

Optano, a leading provider of AI-powered operations solutions, acquired by A.T. Kearney

The private shareholders of Optano GmbH have sold the company to A.T. Kearney. Optano will support them on operation engagements, chiefly in AI-powered supply chain projects, and large-scale operation transformations.

Mehr erfahren
BRM has been acquired by Alta Resources
Dienstleistungen | TMT

BRM has been acquired by Alta Resources

The shareholders of BRM have sold the company to Alta Resources, a leading customer relations business process outsourcer.

Mehr erfahren